MwanzoSCNI • NASDAQ
add
Scinai Immunotherapeutics Ltd - ADR
Bei iliyotangulia
$ 3.53
Bei za siku
$ 3.46 - $ 3.58
Bei za mwaka
$ 2.34 - $ 8.92
Thamani ya kampuni katika soko
3.05M USD
Wastani wa hisa zilizouzwa
elfu 10.23
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | elfu 168.00 | — |
Matumizi ya uendeshaji wa biashara | 2.17M | 3.28% |
Mapato halisi | 10.46M | 236.50% |
Kiwango cha faida halisi | elfu 6.22 | — |
Mapato kwa kila hisa | — | — |
EBITDA | -1.92M | 1.79% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 1.03M | -83.78% |
Jumla ya mali | 12.26M | -34.02% |
Jumla ya dhima | 2.26M | -89.39% |
Jumla ya hisa | 10.00M | — |
hisa zilizosalia | elfu 853.00 | — |
Uwiano wa bei na thamani | 0.30 | — |
Faida inayotokana na mali | -44.63% | — |
Faida inayotokana mtaji | -48.85% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 10.46M | 236.50% |
Pesa kutokana na shughuli | -2.04M | 8.28% |
Pesa kutokana na uwekezaji | elfu -4.00 | 80.00% |
Pesa kutokana na ufadhili | elfu 8.00 | -99.26% |
Mabadiliko halisi ya pesa taslimu | -1.92M | -67.45% |
Mtiririko huru wa pesa | -2.48M | -53.77% |
Kuhusu
BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases.
In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis. Wikipedia
Ilianzishwa
1 Jan 2003
Tovuti
Wafanyakazi
31
